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Cells transformed by Kirsten murine sarcoma virus (Ki-MSV) have basal adenylate cyclase activity (AC) higher than control cells and comparable 
level of forskohn-stimulated AC activity. Moreover, a htgher protem kinase C (PKC) activtty was found to be present in the transformed cells. 
The molecular mechanism underlying the Increase of AC activtty was mvesttgated. Our findmgs strongly suggest that this biochemtcal event is due 
to a marked decrease of the LX, negative control of the enzyme. even though the a, of transformed cells appears to possess fully functional domains 
Interacting wtth both the effector enzyme and the agonist-acttvated receptor. 
ras oncogene, Cell transformation; G-protein: Adenylate cyclase; Protem kinase C 
1. INTRODUCTION 
It is known that in cell transformation induced by ras 
oncogenes there is a marked modification of gene ex- 
pression leading to significant changes of various cell 
differentiation characteristics. Most importantly, it has 
been suggested that the changes observed in the plasma 
membrane signaling metabolic pathways of ras-trans- 
formed cells could play a crucial role in the definition 
of the transformed cell phenotype [l]. 
The optimal activity of the CAMP signaling pathway 
occurring in the plasma membrane of eukaryotic cells, 
depends on the coordinate expression of three major 
protein components (receptor, transducer, amplifier). 
The expression of these specific proteins can be altered 
by cell transformation. An analysis of the relationship 
between the normal functions of this pathway and the 
process of gene expression could be of interest in eluci- 
dating the role played by the plasma membrane signal- 
ing pathways in differention of eukaryotic cells. 
We investigated this problem by studying the CAMP 
signaling pathway in the rat seminal vesicle epithelial 
cell line SVCl and in the corresponding Ki-MSV trans- 
formed cells (Ki-SVCl). The SVCl clone is an andro- 
gen-dependent cell line derived from the Wistar-Fisher 
rat seminal vesicle secretory epithelium [2]. These cells, 
having a duplication time of about 24 h, retain in vitro 
differentiation markers such as the ability to synthetize 
and secrete in the medium a number of proteins, some 
of which are antigenically related to the protein SV-IV 
*Corresponding author. Fax: (39) (81) 566 5863. 
specific for this tissue. The infection of SVCl with Ki- 
MSV. containing the v-ras-Ki oncogene. caused marked 
morphological changes, acquisition of typical neoplas- 
tic characteristics (growth in semisolid medium and in- 
duction of tumors after subcutaneous injection of trans- 
formed cells into singeneic rats) and a 25% decrease in 
their duplication time [3]. Transglutaminase (EC 
2.3.2.13) activity was reduced to a half after cell trans- 
formation [4]. Dot-blot mRNA/cDNA hybridization 
experiments and immunological analyses of the proteins 
secreted from the normal and transformed SVCl cells. 
indicate that the presence in the cells of oncogene v-ras- 
Ki decreases (20%) the expression of the gene coding for 
the SV-IV related antigens (unpublished data). Testos- 
terone (TST) induced a mitogenic stimulus on both 
SVCl and Ki-SVCl cells. The Ki-SVCI were less sensi- 
tive than SVCl cells to mitogenic TST stimulus: lo-fold 
higher hormone concentrations were required to 
achieve a comparable proliferative response. The ex- 
pression of specific TST receptors increased about three 
times in transformed cells (unpublished data). Further- 
more, by using immunological techniques and the Fluo- 
rescence Activated Cell Sorter (FACS) it has been 
shown that in Ki-MSV infected cells the expression of 
genes coding for class I MHC antigens increases about 
10 times [3]. 
In the present paper we report data showing that the 
ras-induced transformation of SVCl cells produces a 
marked increase of both AC and PKC activities. The 
molecular mechanism underlying the increase in the ac- 
tivity of AC has been investigated and the results were 
discussed. 
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2. MATERIALS AND METHODS 
2.1. Materials 
The following materials were obtained from the indicated sources: 
[a-32P]ATP (29.6 TBq/nmol) and [LY-~*P]NAD (29.6 TBq/mmol) from 
Du Pont-New England Nuclear; pertussis toxin (PT) from Sigma 
Chemical Co. 
The sources of all other materials are described where required. 
2.2. Cell Culture 
SVCl and KI-SVCl were cultured in Dulbecco’s modified Eagle’s 
medium (DMEM) supplemented with 10% fetal calf serum, 2 mM 
glutamme, 100 U/ml penicillin, 100 &ml streptomicin and 10 U/ml 
mycostatin. The cells were mantained at 37°C in an humidified atmos- 
phere of 5% C02/95% air. The medium was changed every two days 
L-41. 
2.3. Membrane preparation 
The monolayer confluent cells were scraped, washed three times in 
PBS and the final pellet suspended m a sucrose sahne buffer (0.33 M 
sucrose; 20 mM Tris-HCl, pH 7.5, 2 mM EDTA, 0.5 mM EGTA. 
2 mM PMSF. 5 pg/rnl leupeptm) at a final concentration of 4 
6x106cells/ml. Three ml ahquots of cell suspension were homogenized 
with a loose-fitting glass-glass Dounce homogenizer (30 strokes). The 
membrane pellet, obtained by centrifugation of the homogenate at 
27,000 x g for 20 mm at 4”C, was resuspended in the specific buffer 
required m the different types of assay. 
2.4. Cell treatment wrth TPA 
Confluent cell cultures were incubated for 10 min m the presence 
of their culture medium supplemented with a final concentration of 
1 ,LLM 12-0tetradecanoylphorbol 13-acetate (TPA) in 0 1% DMSO. 
Controls were obtained incubating the cells m the same culture me- 
dium supplemented with the corresponding volume of 0.1% DMSO 
used as TPA solvent. 
2.5. CL, ADP-rlbosylation m vwo 
This assay was carried out according to Kopf and Woolkahs [5] by 
using confluent monolayer cells and 10 ng PT per ml of culture me- 
dium After 18 h. the cells were used for membrane preparation to 
evaluate their AC and protein kinase activities. 
2.6. Adenylate cyclase assa) 
The AC assay was performed according to a published procedure 
[6]. The reaction mixture contained, in a final volume of 100,~L 50-100 
pg of membrane proteins as enzyme source. Forskolm, NaF and 
mastoparan were added to the incubation mixture as AC modulators 
at the final concentration reported in Figures or Tables. The AC- 
specific activity was expressed as [3’P]cAMP formed per mg of mem- 
brane proteins. The c-AMP was recovered from reaction mixtures by 
chromatographic procedures [7]. 
2.7. Protem kinase actwities 
The incubation mixture used for evaluation of PK activity con- 
tamed in a final volume of 250 ~1: 25550 pg of enzymic source. 20 mM 
Tris-HCl, pH 7.5.0.75 mM CaCl,, 1OmM magnesium acetate, 0.1 mM 
ATP, 0.2 mg/ml histone Hl(Boehringer), 0.05 mg/ml leupeptin, 
[Y-~‘P]ATP (500 Ci/mmol, NEN-Du Pont). The PKC activity was 
triggered by adding to the reaction mixture 1.6 pg of 1,2-diolein and 
24 pg phosphatidyl-serine in 20 mM Tris-HC1 pH 7.5. The reaction 
was carried out for 3 min at 30°C and then terminated by addition of 
lml of cold 25% TCA. Samples were filtered through Milhpore filters 
(0.45 pm) and the radioactivity of dry filters was measured by a liquid 
scintillation counter [S]. The PK or PKC specific activity was ex- 
pressed as nmoles of “P-phosphate mcorporated/mg protein/min. The 
enzymic sources used were proteins of the cytosolic fraction (obtained 
as supernatant of 27,000 x g, 20 min centrifugation of cell homoge- 
nates) and membrane proteins partially purified by DEAE cellulose 
chromatography [9]. 
2.8. Immunodetectlon of aG-protems 
Proteins from membrane preparations were separated by SDS- 
PAGE on 10% polyacrylamide gels [lo]. and transferred onto mtrocel- 
lulose sheets (Schleicher & Schuell) with a Trans-Blot apparatus (Bio- 
Rad). The anti-a,G-proteins antibodies were purchased from NEN- 
Du Pont. Goat rabbit anti-IG antibodies. conmgated with alkahne 
phosphatase (BioRad) were used as detection system accordmg to the 
manufacturer instructions. 
2.9. Protem concentratron measure 
The protein concentration was determined according to Bradford 
[ill. 
3. RESULTS AND DISCUSSION 
3.1. Basal and F, but not forskolin-stimulated, AC ac- 
tivity is markedly increased in Ki-MSV-transformed 
cells 
The results reported in Table I show that ras-virus 
transformed cells have a markedly higher basal AC ac- 
tivity compared with the control cells (four times in- 
crease). The increase is also present when the enzymic 
activity is stimulated by F-. In contrast. when AC is 
directly stimulated by forskolin, both control and ras- 
virus transformed cells show a comparable level of en- 
zymic activity. 
3.2. The level of G-protein a, component is signiJicant1~~ 
louyer in Ki MSV-transformed cells 
It is well established that adenylate cyclase enzyme is 
under control of two families of GTP-binding proteins 
(G, and G, proteins). These proteins connect the cata- 
lytic protein with receptors activated by stimulatory or 
inhibitory external signals. Both G-proteins are hetero- 
trimers (CL + /3 + r), differing for the CI component sub- 
unit (a, or 01,) which binds GTP and swings, because of 
its intrinsic GTPase activity, between an active GTP- 
bound and an inactive GDP-bound structure [12]. In 
basal conditions, i.e. in the absence of known external 
signals, a continous inhibitory modulation is operated 
mainly by 01,. The finding that no difference was ob- 
served between the AC activity of SVCl and Ki-SVCl 
cells when the enzymic activity was directly stimulated 
with forskolin [ 131 bypassing the G-protein modulation, 
led us to suppose that an impaired CI, control could be 
Table I 
Adenylate cyclase activity SVCl and Ki-SVCl epithelial cells” 
Addition AC (pmol cAMP/mg protemjmin) 
SVCl Ki-SVCl 
None 23 + 0.11 79 ?r 1.5 
Forskohn (lo-’ M) 421 f 19 400 f 13 
NaF (lo-’ M) 137 * 7.9 2062 9 
d For experimental details. see Section 2. Each value represents the 
mean f S.D. of at least three independent determinations performed 
m triplicate. 
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at the basis of the increased AC activity in the trans- 
formed cells. To verify this hypothesis. we measured by 
immunologic methods the levels of as/a, proteins in con- 
trol and transformed cells. The results shown in Fig. 1 
indicate that the cr, amount is substantially lower in 
transformed than in control cells. By considering the 
continous inhibitory role of a, on the AC enzyme, this 
finding strongly supports the above-mentioned hypoth- 
esis. 
3.3. Pertussis toxin-mediated a, ADP-ribosylation is 
more effective in Ki-MSV-transformed cells 
To further investigate the role of a, in the molecular 
mechanism underlying the increase of AC activity in 
transformed cells, the control and ras-virus transformed 
cells were treated in vivo with PT in order to obtain 
a,-ADP-ribosylation and hence, its functional exclusion 
from AC modulation [ 141. The results reported in Fig. 2 
indicate that PT is much more effective in increasing AC 
activity in Ki-SVCl than in SVCI cells. Several mecha- 
nisms might be at the basis of this result: (i) the lower 
CL, amount in transformed cells could allow the PT to 
perform a maximal ADP-ribosylation; (ii) the toxin 
could find in transformed cells more favorable condi- 
tions for its activity [15]: (iii) both mechanisms could 
operate at same time. 
3.4. The ‘cross talk’ between PKC and AC is more in- 
tense in Ki-MS V transformed S V cells 
The AC signaling pathway has been shown to be 
connected and modulated by enzymic activities operat- 
ing on other distinct signaling pathways [16]. As far as 
the Ca’+, diacylglycerol, phosphatydylserine-dependent 
Table II 
Cytosolic and membrane-bound protem kinase activittes m SVCl and 
Ki-SVCl” 
Enzymic source nmol “P incorporated/mg protein/min 
Addition Calculated 
PKC (B-A) 
None (A) Ca” + PLb (B) 
Crude cytosol 
SVCl 1.05 f 0.02 1.19 f 0.03 0.14 
Ki-SVCl 1.86 f 0.02 3.75 2 0.04 1.89 
M 100’ 
SVCl 6.90 + 0.17 8.69 + 0.23 1.79 
Ki-SVC 1 0.39 * 0.01 0.59 + 0.03 0.2 
M 350’ 
SVCl 3.99 * 0.10 2.50 + 0.08 
Ki-SVCl 1.75 ? 0.03 1.73 + 0.05 
*For experimental details. see Section 2. Each value represents the 
mean ? S.D. of at least three independent determinations performed 
in triplicate 
’ PL means: diacyl-glycerol + phosphatidyl-serme 
’ M 100 and M350 refer to solubtlized membrane proteins. eluted from 
DE52 column by 100 mM and 350 mM NaCl. respectively. 
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Fig. 1. Immunological detection of a, and a, in the protein extract of 
SVCl or Ki-SVCI cell membranes. Western blot of SVCl or KI-SVCl 
membrane proteins. Ftfty pg of crude cell membranes were fraction- 
ated on 10% SDS gels. transferred to mtrocellulose and probed with 
antisera raised agamst a, or a,. For experimental details. see Section 2. 
protein kinases (PKC), these enzymes phosphorylate 
and functionally modulate either one of the three molec- 
ular components (receptor, a-G-protein subunit and 
cyclase enzyme) of the AC signaling pathway. depend- 
ing on the investigated system [17-191. We have found 
that in another epithelial cell line derived from rat thy- 
roid the ras virus transformation produced increased 
AC and PKC activities together with an increased level 
of intracellular CAMP [6,8]. On the basis of these find- 
ings and considerations we have investigated the protein 
kinase activities in control and transformed cells. 
The data reported in Table 11 show that the protein 
kinase activity distribution between cytoplasm and 
membrane in control cells is different from that occur- 
ring in Ki-MSV transformed cells. In the latter the PKC 
activities are higher in cytoplasm than in membranes. 
It has been shown that PKC phosphorylates the a: sub- 
unit of the Gi proteins [16] and that the resulting cova- 
lent modification produces ~1, functional inhibition and 
an enhanced AC activity. By considering the different 
PKC cellular distribution in control and ras-virus trans- 
formed cells, it seemed of interest to investigate whether 
an in vivo PKC activation by 12-O-tetradecanoylphor- 
bol 13-acetate (TPA) could have differentially affected 
the AC in the two cellular types. TPA is a well known 
tumor promoting agent, which acts on PKC activation 
and translocation from cytosol to membrane because of 
a structural similarity with the physiological activator 
diacyl-glycerol [ZO]. 
The results reported in the Table III indicate that that 
1 ,uM TPA. is able to markedly increase, already after 
10 min, the membrane-bound AC activity in virus trans- 
formed cells. while it does not have any effect on the AC 
of control cells. The results suggest that TPA in trans- 
formed cells can activate and translocate to plasma 
membrane an amount of PKC sufficient to phospho- 
rylate and functionally exclude 01, so that the AC activity 
was enhanced. 
The experimental results, so far described. converge 
on indicating that the AC basal activity is stronger in 
transformed than in control cells, because of a de- 
creased a, inhibitory modulation on AC activity. The 
Volume 331, number 1,2 FEBS LETTERS 
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Fig. 2. The effect of PT treatment on AC activity of SVCl or Ki-MSV- 
transformed (Ki-SVCl) epithelial cells. Black bars refer to untreated 
cells; white bars refer to PT-treated cells. Specific AC activity is respec- 
tively 23.3 f 0.9 and 79.4 f 2.1 m SVCl and Ki-SVCl. For experi- 
mental details. see Sectton 2. 
decreased modulation, in turn. could be due to a dimin- 
ished concentration of a, associated with its higher sus- 
ceptibility to covalent modification by either PT or 
PKC. This consideration suggests that in transformed 
cells the increase in the AC activity could result from a 
tighter connection with a PKC-mediated signal 
transducing pathway. 
3.5. The a, interaction with the agonist-activated recep- 
tors and AC is equally effective in both control and 
transformed cells 
The above reported results do not exclude that a, of 
transformed cell might be mutated either in the domain 
interacting with agonist-activated receptors or in the 
domain interacting with AC, or in both of them. We 
have functionally approached the problem by studying 
the AC activity of control and transformed cell mem- 
branes in presence or in absence of 0.3 ,uM mastoparan. 
Mastoparan is a fourteen residues amphiphylic peptide 
present in wasp venoms, which inserts it self in the 
Table III 
The effects of TPA on AC activity in SVCl or Ki-SVCl celsl” 
Cells AC activity 
(pmol cAMP/mg protem/min) 
- TPA (vehicle)b + TPA 
SVCl 69.1 f 5.5 65.3 f 10.7 
Ki-SVCl 151.8 + 6.3 273.4 + 12.8 
*For experimental details, see Section 2. Each value represents the 
mean f S.D. of at least three mdependent determinations performed 
in trtplicate. 
‘0.1% dimethyl sulfoxide (DMSO) solution is used to dissolve TPA 
and rt is able to increase, by itself, the AC activity both in control and 
in transformed cells. We have previously shown that the DMSO 
effect on AC is aspecific because of its attitute to interact with mem- 
brane lipids and its ability to decrease the membrane microvtscosity. 
September 1993 
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Fig. 3. The mastoparan effect on the basal or forskolin-strmulated AC 
activrty of SVCl and Ki-SVCl cell membranes. (1) basal: (2) + for- 
skolin; (3) + mastoparan; (4) + forskolin and mastoparan. For other 
experimental details. see Section 2. 
membrane phospholipid bilayer and activates a, by 
mimicking the domain of the agonist-activated receptor 
interacting with the G,-protein [21]. The results shown 
in Fig. 3 indicate that mastoparan is effective in decreas- 
ing AC activity in transformed cell membranes and sug- 
gest that the a, present in these membranes possesses 
domains interacting with agonist-activated receptors 
and AC as efficiently as in controls. 
4. CONCLUDING REMARKS 
We have shown that Ki-ras-induced transformation 
is accompanied with an increase in the activity of both 
AC and PKC-associated signaling pathways. From the 
data obtained it appears that the molecular mechanism 
underlying this biochemical event could be a decrease 
of a, concentration combined with a tighter PKC-medi- 
ated control of a,. Activation of p21’““, as measured by 
the transition from its inactive GDP-bound state to the 
active GTP-bound conformation, is considered a final 
and essential step in driving quiescent cells in to DNA 
replication process. Growing evidence suggests that dis- 
tinct mitogen signaling pathways triggered either by 
ligands of receptor tyrosine kinases, such as insulin or 
epidermal growth factor (EGF), or by ligands not di- 
rectly activating tyrosine kinases, such as thrombin and 
LPA (lipid lysophosphatidic acid), converge to a ~21’“” 
activation process as to a metabolic cross-point leading 
to DNA replication [22]. It is generally accepted that 
one of the first events in the process of ras-induced 
transformation is represented by an intracellular in- 
crease of the ~21”” concentration. The component of 
this protein family expressed by the viral genome pos- 
sesses a deficient intrinsic GTPase activity as a conse- 
quence of a point mutation of its gene and remains, 
therefore, for a longer time in the active GTP-bound 
state. The role played by activated ~21” in the trigger- 
ing and regulation of DNA replication is well estab- 
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lished. although still unknown in its molecular details. 
Therefore, significant changes in the biochemical phe- 
notype of transformed cells are to be expected. The 
challenge is to identify in the transformed cells the main 
metabolic steps leading from an altered membrane sig- 
naling pathway, such as the c-AMP pathway, to various 
changes in the normal program of gene expression and 
regulation of DNA replication. 
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